Provided by Tiger Trade Technology Pte. Ltd.

Xencor

24.84
+0.07000.28%
Post-market: 25.230.3900+1.57%19:41 EDT
Volume:1.10M
Turnover:27.18M
Market Cap:1.84B
PE:-11.41
High:25.50
Open:25.36
Low:24.14
Close:24.77
52wk High:30.61
52wk Low:10.38
Shares:74.13M
Float Shares:54.25M
Volume Ratio:0.79
T/O Rate:2.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1768
EPS(LYR):-1.2400
ROE:-29.07%
ROA:-16.83%
PB:3.66
PE(LYR):-20.03

Loading ...

Xencor Is Maintained at Neutral by JP Morgan

Dow Jones
·
May 12

Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (DNA), Xencor (XNCR) and Alto Neuroscience, Inc. (ANRO)

TIPRANKS
·
May 11

Xencor price target raised to $14 from $13 at JPMorgan

TIPRANKS
·
May 11

Wedbush Remains a Buy on Xencor (XNCR)

TIPRANKS
·
May 09

Piper Sandler Reaffirms Their Buy Rating on Xencor (XNCR)

TIPRANKS
·
May 08

Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Oscar Health (OSCR) and REPRO-MED Systems (KRMD)

TIPRANKS
·
May 07

Bank of America Securities Reaffirms Their Hold Rating on Xencor (XNCR)

TIPRANKS
·
May 07

Xencor reports Q1 EPS ($1.71), consensus (75c)

TIPRANKS
·
May 07

Xencor Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Xencor Q1 EPS $(1.71) Misses $(0.75) Estimate, Sales $4.516M Miss $27.760M Estimate

Benzinga Earnings
·
May 07

Xencor Q1 net loss widens to $128.9 million; revenue drops to $4.5 million

Reuters
·
May 07

BRIEF-Xencor Q1 EPS USD -1.71

Reuters
·
May 07

Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), DENTSPLY SIRONA (XRAY) and Neurocrine (NBIX)

TIPRANKS
·
May 06

Buy Rating on Xencor as TL1A Franchise Data and Upcoming Phase IIb Catalyst Support Upside Potential

TIPRANKS
·
May 06

Xencor to host webcast to discuss XmAb942, XmAb412 data presentations

TIPRANKS
·
May 04

Xencor schedules Phase 2b XmAb942 ulcerative colitis trial 12-week results for 2027

Reuters
·
May 04

Xencor announces annual shareholder meeting

Reuters
·
Apr 28

Top Xencor Executive Quietly Cashes Out a Chunk of Company Stock

TIPRANKS
·
Apr 14